Angiotensin II: A Review of Current Literature.
J Cardiothorac Vasc Anesth
; 36(4): 1180-1187, 2022 04.
Article
em En
| MEDLINE
| ID: mdl-34452817
ABSTRACT
Up to one-third of all patients admitted to intensive care units carry a diagnosis of shock. The use of angiotensin II is becoming widespread in all forms of shock, including cardiogenic, after the U.S. Food and Drug Administration's (FDA's) initial approval for vasoplegic shock in 2017. Here, the authors review the literature on angiotensin II's mechanism of action, benefits, and future therapeutic opportunities.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Choque
/
Vasoplegia
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
J Cardiothorac Vasc Anesth
Assunto da revista:
ANESTESIOLOGIA
/
CARDIOLOGIA
Ano de publicação:
2022
Tipo de documento:
Article